Coherus BioSciences Inc (CHRS)
Healthcare
Biotechnology
1.40 $
-4.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Coherus BioSciences Inc (CHRS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.9% of the shares are freely tradable; institutional investors hold 38.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
38.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
18.7%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
85.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
17.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
154Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 6.72 | 10,365,074 | -1.9 | 03/31/2026 |
| Vanguard Group Inc | 6.50 | 10,028,893 | -2.8 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.54 | 5,452,762 | +0.0 | 03/31/2026 |
| Samsara BioCapital, LLC | 2.22 | 3,428,571 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 2.02 | 3,121,578 | +13.7 | 03/31/2026 |
| Kohlberg Kravis Roberts & Co LP | 1.97 | 3,036,076 | +0.0 | 03/31/2026 |
| State Street Corp | 1.51 | 2,325,859 | +4.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| HBM Healthcare Investments AG Ord | 2.41 | 3,714,285 | +0.0 | 03/31/2026 |
| Vanguard Total Stock Mkt Idx Inv | 2.35 | 3,629,417 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 1.57 | 2,419,989 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.